7R69 image
Deposition Date 2021-06-22
Release Date 2022-07-06
Last Version Date 2023-10-25
Entry Detail
PDB ID:
7R69
Keywords:
Title:
Crystal structure of mutant R43D/C273S of L-Asparaginase I from Yersinia pestis
Biological Source:
Source Organism:
Yersinia pestis (Taxon ID: 632)
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.19
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:L-asparaginase I
Gene (Uniprot):ansA
Mutations:R43D, C273S
Chain IDs:A, B, C, D
Chain Length:338
Number of Molecules:4
Biological Source:Yersinia pestis
Ligand Molecules
Primary Citation
The dimeric form of bacterial l-asparaginase YpAI is fully active.
Febs J. 290 780 795 (2023)
PMID: 36152020 DOI: 10.1111/febs.16635

Abstact

l-asparaginases from mesophilic bacteria (ASNases), including two enzymes very successfully used in the treatment of leukaemia, have been consistently described as homotetramers. On the contrary, structural studies show that homodimers of these enzymes should be sufficient to carry out the catalytic reaction. In this report, we investigated whether the type I Yersinia pestis asparaginase (YpAI) is active in a dimeric form or whether the tetrameric quaternary structure is critical for its activity. Using multiple biophysical techniques that investigate enzymatic properties and quaternary structure at either high or low protein concentration, we found that dimeric YpAI is fully active, suggesting that the tetrameric form of this subfamily of enzymes does not bear significant enzymatic relevance. In this process, we extensively characterized YpAI, showing that it is a cooperative enzyme, although the mechanism of allostery is still not definitely established. We showed that, like most type I ASNases, the substrate affinity of YpAI is low and this enzyme is very similar in terms of both the structure and enzymatic properties to homologous type I ASNase from Escherichia coli (EcAI). We extended these studies to more medically relevant type II ASNases, used as anti-leukaemia drugs. We confirmed that type II ASNases are not allosteric, and that they might also be functional in a dimeric form. However, the determination of the accurate tetramer⇆dimer dissociation constants of these enzymes that most likely lie in the picomolar range is not possible with currently available biophysical techniques.

Legend

Protein

Chemical

Disease

Primary Citation of related structures